glycidyl nitrate has been researched along with Eczema, Atopic in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 8 (47.06) | 29.6817 |
| 2010's | 8 (47.06) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bäumer, W; Ehling, S; Glatzer, F; Gschwandtner, M; Gutzmer, R; Janik, K; Kietzmann, M; Klos, A; Rossbach, K; Werfel, T | 1 |
| Jeong, MS; Joo, SS; Kim, JY; Lee, MW; Park, EJ; Park, KH; Park, KY; Seo, SJ | 1 |
| Matsushita, S; Miyano, K; Nakamura, K; Tsuchida, T | 1 |
| Lutat, C; Niebuhr, M; Sigel, S; Werfel, T | 1 |
| Langnickel, J; Niebuhr, M; Sigel, S; Werfel, T | 1 |
| Matsui, K; Mungmee, C; Nishikawa, A; Thanakijcharoenpath, W; Wirotesangthong, M | 1 |
| Heratizadeh, A; Niebuhr, M; Satzger, I; Werfel, T; Wichmann, K | 1 |
| Matsui, K; Nishikawa, A | 4 |
| Barnes, KC; Beck, LA; Borkowski, AW; Carpenter-Mendini, A; De Benedetto, A; Gallo, RL; Georas, SN; Ivanov, AI; Kuo, IH; Leung, DY; McGirt, LY; Yamasaki, K; Yoshida, T | 1 |
| Arimura, A; Hikita, I; Hirasawa, T; Horikawa, T; Imura, K; Matsutani, T; Sakata, T; Yoshioka, T | 1 |
| Matsui, K; Nishikawa, A; Wirotesangthong, M | 1 |
| Draing, C; Kapp, A; Langnickel, J; Niebuhr, M; Renz, H; Werfel, T | 1 |
| Matsui, K; Motohashi, R; Nishikawa, A | 1 |
| König, W; Neuber, K | 1 |
17 other study(ies) available for glycidyl nitrate and Eczema, Atopic
| Article | Year |
|---|---|
Histamine induces proliferation in keratinocytes from patients with atopic dermatitis through the histamine 4 receptor.
Topics: Animals; Cell Line; Cell Proliferation; Dermatitis, Atopic; Female; Gene Expression Regulation; Histamine; Histamine Antagonists; Humans; Indoles; Keratinocytes; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Peptidoglycan; Piperazines; Receptors, G-Protein-Coupled; Receptors, Histamine; Receptors, Histamine H4 | 2013 |
Effect of topical application of quercetin-3-O-(2″-gallate)-α-l-rhamnopyranoside on atopic dermatitis in NC/Nga mice.
Topics: Administration, Cutaneous; Animals; Cells, Cultured; Cyclooxygenase 2; Dermatitis, Atopic; Eosinophils; Female; Immunoglobulin E; Interleukin-13; Interleukin-4; Interleukin-5; Leukocyte Count; Macrophages; Mice; Nitric Oxide Synthase Type II; Peptidoglycan; Quercetin; RNA, Messenger | 2015 |
Inhibitory effect of a histamine 4 receptor antagonist on CCL17 and CCL22 production by monocyte-derived Langerhans cells in patients with atopic dermatitis.
Topics: Cells, Cultured; Chemokine CCL17; Chemokine CCL22; Dermatitis, Atopic; Humans; Indoles; Langerhans Cells; Monocytes; p38 Mitogen-Activated Protein Kinases; Peptidoglycan; Piperazines; Receptors, G-Protein-Coupled; Receptors, Histamine; Receptors, Histamine H4; Signal Transduction; Staphylococcus aureus; Th2 Cells; Toll-Like Receptor 2 | 2016 |
Impaired TLR-2 expression and TLR-2-mediated cytokine secretion in macrophages from patients with atopic dermatitis.
Topics: Cells, Cultured; Cytokines; Dermatitis, Atopic; Humans; Lipopolysaccharides; Macrophages; Peptidoglycan; Skin; Staphylococcus aureus; Teichoic Acids; Toll-Like Receptor 2 | 2009 |
Dysregulation of CD36 upon TLR-2 stimulation in monocytes from patients with atopic dermatitis and the TLR2 R753Q polymorphism.
Topics: Case-Control Studies; CD36 Antigens; Dermatitis, Atopic; Disease Susceptibility; Humans; Ligands; Lipopolysaccharides; Monocytes; Peptidoglycan; Polymorphism, Single Nucleotide; Skin; Staphylococcal Skin Infections; Staphylococcus aureus; Teichoic Acids; Toll-Like Receptor 2 | 2010 |
Inhibitory effects of Schefflera leucantha extract on production of allergic mediators by Langerhans cells and mast cells.
Topics: Animals; Anti-Allergic Agents; Araliaceae; Chemokine CCL17; Chemokine CCL5; Dermatitis, Atopic; Female; Histamine Release; Langerhans Cells; Mast Cells; Mice; Mice, Inbred BALB C; Peptidoglycan; Plant Extracts | 2010 |
Intrinsic alterations of pro-inflammatory mediators in unstimulated and TLR-2 stimulated keratinocytes from atopic dermatitis patients.
Topics: Case-Control Studies; Chemokines; Cytokines; Dermatitis, Atopic; Gene Expression; Humans; In Vitro Techniques; Inflammation Mediators; Keratinocytes; Lipopolysaccharides; Lipoproteins; Matrix Metalloproteinase 9; Peptidoglycan; RNA, Messenger; Teichoic Acids; Toll-Like Receptor 1; Toll-Like Receptor 2; Toll-Like Receptor 6 | 2011 |
Percutaneous application of peptidoglycan from Staphylococcus aureus induces infiltration of CCR4+ cells into mouse skin.
Topics: Animals; Antigens, Dermatophagoides; Cell Movement; Cells, Cultured; Chemokine CCL17; Chemokine CCL22; Dermatitis, Atopic; Disease Models, Animal; Humans; Immunization; Langerhans Cells; Mice; Mice, Inbred BALB C; Peptidoglycan; Pyroglyphidae; Receptors, CCR4; Skin; Staphylococcus aureus; Th2 Cells; Up-Regulation | 2011 |
Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair.
Topics: Animals; Antibodies, Neutralizing; Bacterial Proteins; Dermatitis, Atopic; Epidermis; Female; Foreskin; Humans; Keratinocytes; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptidoglycan; Permeability; RNA, Messenger; Tight Junctions; Toll-Like Receptor 1; Toll-Like Receptor 2; Transcutaneous Electric Nerve Stimulation; Wound Healing | 2013 |
Effects of the macrolide antibiotic, midecamycin, on Staphylococcus aureus product-induced Th2 cytokine response in patients with atopic dermatitis.
Topics: Adult; Anti-Bacterial Agents; Cytokines; Dermatitis, Atopic; Enterotoxins; Gene Expression Regulation; Gentamicins; Humans; Interleukin-4; Interleukin-5; Leucomycins; Lipopolysaccharides; Macrolides; Peptidoglycan; RNA, Messenger; Staphylococcus aureus; Teichoic Acids; Th2 Cells | 2004 |
Percutaneous application of peptidoglycan from Staphylococcus aureus induces an increase in mast cell numbers in the dermis of mice.
Topics: Abdomen; Administration, Cutaneous; Animals; Antibodies, Monoclonal; Cell Count; Dermatitis, Atopic; Dermis; Female; Immunohistochemistry; Injections, Intraperitoneal; Keratinocytes; Mast Cells; Mice; Mice, Inbred BALB C; Peptidoglycan; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Specific Pathogen-Free Organisms; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Transforming Growth Factor beta | 2005 |
Percutaneous application of peptidoglycan from Staphylococcus aureus induces mast cell development in mouse spleen.
Topics: Administration, Cutaneous; Animals; Carboxypeptidases A; Cell Proliferation; Chymases; Cytokines; Dermatitis, Atopic; Female; Humans; Mast Cells; Mice; Mice, Inbred BALB C; Peptidoglycan; RNA, Messenger; Serine Endopeptidases; Spleen; Staphylococcal Infections; Staphylococcus aureus | 2006 |
Impact of T-cell receptor Vbeta haplotypes on the development of dermatitis in DS-Nh mice: synergistic production of interleukin-13 caused by staphylococcal enterotoxin C and peptide glycans from Staphylococcus aureus.
Topics: Animals; Cell Proliferation; Cells, Cultured; Collagen; Dermatitis, Atopic; Enterotoxins; Genetic Predisposition to Disease; Haplotypes; Interleukin-13; Killer Cells, Natural; Ligands; Lymphocyte Activation; Mice; Mice, Inbred Strains; Peptidoglycan; Polymerase Chain Reaction; Receptors, Antigen, T-Cell, alpha-beta; Spleen; Staphylococcus aureus; Superantigens; Toll-Like Receptor 2 | 2007 |
Peptidoglycan from Staphylococcus aureus induces IL-4 production from murine spleen cells via an IL-18-dependent mechanism.
Topics: Administration, Cutaneous; Animals; Dermatitis, Atopic; Female; Interleukin-18; Interleukin-4; Mice; Mice, Inbred BALB C; Peptidoglycan; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Specific Pathogen-Free Organisms; Spleen; Staphylococcus aureus | 2008 |
Dysregulation of toll-like receptor-2 (TLR-2)-induced effects in monocytes from patients with atopic dermatitis: impact of the TLR-2 R753Q polymorphism.
Topics: Dermatitis, Atopic; Humans; Interleukin-12; Interleukin-6; Ligands; Lipopolysaccharides; Monocytes; Peptidoglycan; Polymorphism, Single Nucleotide; Staphylococcus aureus; Teichoic Acids; Toll-Like Receptor 2 | 2008 |
Cell wall components of Staphylococcus aureus induce interleukin-5 production in patients with atopic dermatitis.
Topics: Adjuvants, Immunologic; Adult; Cell Wall; Cells, Cultured; Dermatitis, Atopic; Humans; Interleukin-5; Lipopolysaccharides; Lymphocytes; Peptidoglycan; Staphylococcus aureus; Teichoic Acids | 2000 |
Effects of Staphylococcus aureus cell wall products (teichoic acid, peptidoglycan) and enterotoxin B on immunoglobulin (IgE, IgA, IgG) synthesis and CD23 expression in patients with atopic dermatitis.
Topics: Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, B-Lymphocyte; Dermatitis, Atopic; Enterotoxins; Humans; Immunoglobulin A; Immunoglobulin E; Immunoglobulin G; Immunoglobulins; Peptidoglycan; Receptors, Fc; Receptors, IgE; Staphylococcus aureus; Teichoic Acids | 1992 |